Latest News

Sex Influences DAPT De-escalation Outcomes Post-PCI
Written by: Interventional Cardiology
Sex Influences DAPT De-escalation Outcomes Post-PCI
Tirzepatide Linked to Lower Cardiorenal Events vs Dulaglutide
Written by: Radcliffe CKM
Tirzepatide Linked to Lower Cardiorenal Events vs Dulaglutide
Finerenone Approved in EU for HF with LVEF ≥40%
Written by: Heart Failure Academy
Finerenone Approved in EU for HF with LVEF ≥40%
SOUL: Oral Semaglutide Improves CV Risk Factors in T2D
Written by: Radcliffe CKM
SOUL: Oral Semaglutide Improves CV Risk Factors in T2D
Ez-PAVE: Lower LDL-C Target Reduces CV Events
Written by: Radcliffe CVRM
Ez-PAVE: Lower LDL-C Target Reduces CV Events
LBBAP Not Non-Inferior to BiVP for CRT in LBBB Patients
Written by: Arrhythmia and Electrophysiology Review
LBBAP Not Non-Inferior to BiVP for CRT in LBBB Patients
PFA for Atrial Flutter: ADVANTAGE AF Substudy Results
Written by: Arrhythmia Academy
PFA for Atrial Flutter: ADVANTAGE AF Substudy Results
hsCRP Improves CV Risk Prediction in Primary Prevention
Written by: Radcliffe CVRM
hsCRP Improves CV Risk Prediction in Primary Prevention
Smartwatch Screening Boosts AF Detection in High-Risk Patients
Written by: Arrhythmia Academy
Smartwatch Screening Boosts AF Detection in High-Risk Patients
Smartwatch Data Predicts Heart Failure Exacerbations
Written by: CFR Journal
Smartwatch Data Predicts Heart Failure Exacerbations

External news

Written by: Medscape
Why Readiness Is Not a Prerequisite for Lifestyle Change
Written by: Medscape
What Is the Evidence Behind the New Dyslipidemia Guideline?
Written by: Medscape
AI's Prescription for Moral Injury
Written by: Cardiovascular Business
More than 11K bottles of blood pressure drug recalled
Written by: Cardiovascular Business
Cardiologists and surgeons share early feedback after CMS proposed sweeping TAVR changes
Written by: Cardiovascular Business
Cardiology still one of the top specialties for FDA-cleared AI algorithms
Written by: Cardiac Vascular News
VahatiCor Enrolls First U.S. Patient in SERRA-I Clinical Study of A-FLUX Reducer System® for CMD
Written by: Medscape
Hypotension Emerges as Top CVD Factor Linked to AD
Written by: Cardiac Vascular News
AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)
Written by: Medscape
5 Critical Mistakes Doctors Make in Managing CKM